We are live on ! Find out more
LIP

Liontrust Investment Partners Portfolio holdings

AUM $5.86B
1-Year Est. Return 23.75%
This Fund
S&P 500
This Quarter Est. Return
+0.53%
1 Year Est. Return
+23.75%
3 Year Est. Return
+74.7%
5 Year Est. Return
10 Year Est. Return
AUM
$7.04B
AUM Growth
-$135M
Cap. Flow
-$106M
Cap. Flow %
-1.51%
Top 10 Hldgs %
30.63%
Holding
236
New
42
Increased
50
Reduced
109
Closed
17

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$121M
2
ADBE icon
Adobe
ADBE
+$106M
3
ILMN icon
Illumina
ILMN
+$66.8M
4
TREX icon
Trex
TREX
+$34.4M
5
ADSK icon
Autodesk
ADSK
+$31.9M

Sector Composition

Rank Sector Weight
1 Technology 33.67%
2 Healthcare 17.65%
3 Financials 15.07%
4 Industrials 10.45%
5 Communication Services 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WAT icon
151
Waters Corp
WAT
$40.7B
$1.78M 0.03%
6,120
CSX icon
152
CSX Corp
CSX
$92.5B
$1.73M 0.02%
51,687
DLR icon
153
Digital Realty Trust
DLR
$70.6B
$1.7M 0.02%
11,178
LGIH icon
154
LGI Homes
LGIH
$1.34B
$1.67M 0.02%
18,672
-175,505
-90% -$16.9M
MRNA icon
155
Moderna
MRNA
$24.2B
$1.54M 0.02%
13,000
-85,000
-87% -$10.8M
MRVL icon
156
Marvell Technology
MRVL
$191B
$1.45M 0.02%
20,708
+2,874
+16% +$201K
GLOB icon
157
Globant
GLOB
$1.68B
$1.43M 0.02%
8,038
+3,228
+67% +$569K
VALE icon
158
Vale
VALE
$60.9B
$1.34M 0.02%
120,000
-105,000
-47% -$1.26M
GPN icon
159
Global Payments
GPN
$22.7B
$1.34M 0.02%
13,834
-148,950
-92% -$16.4M
TRUP icon
160
Trupanion
TRUP
$1.34B
$1.32M 0.02%
44,900
+16,100
+56% +$426K
ALNY icon
161
Alnylam Pharmaceuticals
ALNY
$29.6B
$1.24M 0.02%
5,083
+4,933
+3,289% +$779K
FN icon
162
Fabrinet
FN
$18.8B
$1.22M 0.02%
+5,000
New +$1.06M
ZBH icon
163
Zimmer Biomet
ZBH
$18.5B
$1.19M 0.02%
11,008
-123,287
-92% -$14.5M
ALGN icon
164
Align Technology
ALGN
$12.3B
$1.18M 0.02%
4,903
-25,234
-84% -$7.03M
DAL icon
165
Delta Air Lines
DAL
$59.5B
$1.11M 0.02%
23,399
-234,897
-91% -$11.7M
TAP icon
166
Molson Coors Class B
TAP
$7.83B
$1.1M 0.02%
21,646
-185,473
-90% -$10.7M
NU icon
167
Nu Holdings
NU
$65.9B
$1.1M 0.02%
85,000
-7,000
-8% -$81.5K
IBP icon
168
Installed Building Products
IBP
$6.63B
$1.03M 0.01%
5,005
-90,484
-95% -$20.4M
VRRM icon
169
Verra Mobility
VRRM
$726M
$1.02M 0.01%
37,396
BCO icon
170
Brink's
BCO
$4.69B
$992K 0.01%
9,688
HAS icon
171
Hasbro
HAS
$13.7B
$980K 0.01%
16,759
-235,512
-93% -$14M
LAUR icon
172
Laureate Education
LAUR
$5.05B
$971K 0.01%
65,000
+8,000
+14% +$120K
CIB icon
173
Grupo Cibest SA
CIB
$23.3B
$914K 0.01%
28,000
+5,000
+22% +$172K
VIST icon
174
Vista Energy
VIST
$7.33B
$910K 0.01%
20,000
+7,000
+54% +$310K
MTD icon
175
Mettler-Toledo International
MTD
$28.8B
$862K 0.01%
617
-2,322
-79% -$3.18M

Similar funds

Liontrust Investment Partners's Q2 2024 Portfolio in Review

As of Q2 2024, Liontrust Investment Partners held 236 positions worth $7.04B, down 1.9% from $7.17B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Liontrust Investment Partners's Q2 2024 filing shows 42 new, 50 increased, 109 reduced and 17 closed positions. Its largest new stake was West Pharmaceutical: 194,894 shares worth $64.2M. The largest sale was Equinix, an estimated $121M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

  • Liontrust Investment Partners's largest Q2 2024 buy was West Pharmaceutical: 194,894 shares worth $64.2M.
  • Liontrust Investment Partners added most to Microsoft in Q2 2024, an estimated $197M increase.
  • Liontrust Investment Partners's biggest Q2 2024 reduction was Equinix, cutting an estimated $121M.
  • Liontrust Investment Partners fully exited UnitedHealth in Q2 2024, selling an estimated $20.8M.
  • Liontrust Investment Partners's ten largest holdings make up 31% of its $7.04B portfolio in Q2 2024.
  • Liontrust Investment Partners opened 42 new positions and closed 17 in Q2 2024.
  • Liontrust Investment Partners's portfolio value fell 1.9% quarter-over-quarter to $7.04B.

Based on Liontrust Investment Partners's 13F filing for Q2 2024, filed 26 Jul 2024.